2015 | Cytochrome b5 reductase, a plasma membrane redox enzyme, protects neuronal cells against metabolic and oxidative stress through maintaining redox state and bioenergetics | 현동훈 | Article |
2019 | Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide | 이인혜 | Review |
2016 | Intranasal Delivery of RGD Motif-Containing Osteopontin Icosamer Confers Neuroprotection in the Postischemic Brain via alpha(v)beta(3) Integrin Binding | 한평림 | Article |
2021 | Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2 G2019S Parkinson's Disease Model Mice | 김희선; 박진선 | Article |
2019 | Neuroprotective effect of β-lapachone in MPTP-induced parkinson’s disease mouse model: Involvement of astroglial p-AMPK/Nrf2/HO-1 signaling pathways | 김희선; 박진선; 임예현 | Article |
2022 | Pharmacological mechanism of xanthoangelol underlying Nrf-2/TRPV1 and anti-apoptotic pathway against scopolamine-induced amnesia in mice | 서은경 | Article |
2017 | Repeated Oral Administration of Human Serum Albumin Protects from the Cerebral Ischemia in Rat Brain Following MCAO | 전길자; 이영미 | Article |
2018 | Repression of adenosine triphosphate-binding cassette transporter ABCG2 by estrogen increases intracellular glutathione in brain endothelial cells following ischemic reperfusion injury | 박은미; 류동열; 최윤희; 최지하; 안영호 | Article |
2019 | The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models | 이지희; 김희선; 박은미; 최윤희; 박진선; 임예현 | Article |
2021 | The Potent PDE10A Inhibitor MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced Neuroinflammation and MPTP-Induced Parkinson’s Disease Mouse Models | 김희선; 임예현 | Article |